Manufacturer of Eltrombopag/Eltrombopag ethanolamine tablets

Eltrombopag/EltrombopagThe manufacturers of ethanolamine tablets include British GlaxoSmithKline and Swiss Novartis. This drug is a small molecule non-peptide TPO receptor agonist that can be used to treat thrombocytopenia in patients with chronic idiopathic thrombocytopenia (ITP), severe aplastic anemia (AA), and hepatitis C infection who have failed to respond to glucocorticoids, immunoglobulin therapy or have undergone splenectomy. In addition, there are other manufacturers that may also produce generic drugs, but the specific manufacturers may vary depending on the region and market. Common generic drug manufacturers include Bangladesh Yaopin International, Laos Lucius Pharmaceuticals, India NATCO Pharmaceuticals, etc.